Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Wayne State Receives $2.5M NIH Grant to Study Next-Gen Antibiotics

April 14, 2016 2:01 pm | by Wayne State University | News | Comments

The team's ultimate goal will be to use the data acquired to design the next generation of compounds that will be validated and tested for reduced toxicity and decreased resistance.


Merck Announces Positive Results for Zepatier

April 14, 2016 1:18 pm | News | Comments

The results of C-EDGE Head-to-Head will be featured in the official press program at The International Liver Congress 2016. 


Gut Bacteria Could Help Prevent Cancer

April 14, 2016 1:11 pm | by UCLA | News | Comments

Researchers have shown that various types of intestinal bacteria might be factors in both causing and preventing obesity.


The Direction of the Schizophrenia Drug Pipeline

April 14, 2016 11:40 am | by Stephanie Guzowski, Editor | News | Comments

The small pipeline of schizophrenia products — about 135 products — is indicative of a low level of investment in research and development (R&D). Here's why.


Generic Allergy Drug May Fix Eye Nerve Damage in MS Patients

April 14, 2016 10:39 am | by Ryan Bushey, Digital Editor | Articles | Comments

Scientists discovered this over-the-counter drug could have special properties. 


CDC: Zika Definitely Causes Severe Birth Defects

April 14, 2016 9:12 am | by Mike Stobbe, AP Medical Writer | News | Comments

Confirming the worst fears of many pregnant women in the United States and Latin America, U.S. health officials said Wednesday there is no longer any doubt the Zika virus causes babies to be born with abnormally small heads and other severe brain defects. 


Napster Co-Founder Funds Immunotherapy Research Project

April 14, 2016 8:45 am | by Ryan Bushey, Digital Editor | Articles | Comments

Stanford, Memorial Sloan Kettering Cancer Center, and the University of Pennsylvania are some of the institutions taking part in this endeavor.


Pain Drug in Pipeline as Researchers Unwind Marine Snail Puzzle

April 14, 2016 8:36 am | by University of Queensland | News | Comments

A University of Queensland researcher has made a big step toward the holy grail of biomedical science.


Report: U.S. Prescription Spending Up 8.5 Percent in 2015

April 14, 2016 8:30 am | by Linda Johnson, AP Business Writer | News | Comments

A report from data firm IMS Health estimates patients, insurers, government programs and other payers spent a combined $309.5 billion last year on prescription medicines.


Uncovering Earliest Events Following HIV Infection

April 13, 2016 3:18 pm | by Beth Israel Deaconess Medical Center | News | Comments

New research in monkeys exposed to SIV, the animal equivalent of HIV, reveals what happens in the very earliest stages of infection, before virus is even detectable in the blood, which is a critical but difficult period to study in humans. 


Hepatitis C Testing Guidelines Miss Too Many Cases, Study Suggests

April 13, 2016 3:10 pm | News | Comments

A review of blood samples for nearly 5,000 patients seen at The Johns Hopkins Hospital Emergency Department suggests that federal guidelines for hepatitis C virus (HCV) screening may be missing up to a quarter of all cases and argues for updated universal screening.


Gene Variant Explains Racial Disparities in Urate-Lowering Drug Reactions

April 13, 2016 3:04 pm | by Massachusetts General Hospital | News | Comments

A multi-institutional study led by a Massachusetts General Hospital (MGH) investigator finds significant racial disparities in the risk that patients being treated for gout will develop a serious, sometimes life-threatening adverse reaction to the most commonly prescribed medication.


Shining New Light on Diabetes Treatment

April 13, 2016 11:59 am | by University of Birmingham | News | Comments

​Researchers have developed a light-activated tool to show how drugs need to be adapted to combat type 2 diabetes.


FDA Panel Votes Against Approving Clovis Lung Cancer Drug

April 13, 2016 11:40 am | by Stephanie Guzowski, Editor | News | Comments

A U.S. Food and Drug Administration panel recommended against the accelerated approval of Clovis Oncology’s lung cancer treatment, in a vote of 12 to one. 


'Secret Sauce' for Personalized, Functional Insulin-Producing Cells

April 13, 2016 10:11 am | by Salk Institute | News | Comments

Salk scientists have solved a longstanding problem in the effort to create replacement cells for diabetic patients.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.